Document Detail


The effect of angiotensin-converting enzyme inhibitors of left atrial pressure in dogs with mitral valve regurgitation.
MedLine Citation:
PMID:  20102507     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Despite many epidemiological reports concerning the efficacy of angiotensin-converting enzyme (ACE) inhibitors in dogs with mitral regurgitation (MR), the hemodynamic effects of ACE inhibitor administration have not been fully evaluated.
OBJECTIVES: To document left atrial pressure (LAP) in dogs with MR administered ACE inhibitors, in order to obtain interesting information about daily LAP changes with administration of ACE inhibitors.
ANIMALS: Five healthy Beagle dogs weighing 9.8 to 14.2 kg (2 males and 3 females; aged 2 years).
METHODS: Experimental, crossover, and interventional study. Chordae tendineae rupture was induced, and a radiotelemetry transmitter catheter was inserted into the left atrium. LAP was recorded for 72 consecutive hours during which each of 3 ACE inhibitors--nalapril (0.5 mg/kg/d), temocapril (0.1 mg/kg/d), and alacepril (3.0 mg/kg/d)--were administered in a crossover study.
RESULTS: Averaged diurnal LAP was significantly, but slightly reduced by alacepril (P = .03, 19.03 +/- 3.01-18.24 +/- 3.07 mmHg). The nightly drops in LAP caused by alacepril and enalapril were significantly higher than the daily drops (P = .03, -0.98 +/- 0.19 to -0.07 +/- 0.25 mmHg, and P = .03, -0.54 +/- 0.21-0.02 +/- 0.17 mmHg, respectively), despite the fact that the oral administrations were given in the morning. Systolic blood pressure (122.7 +/- 14.4-117.4 +/- 13.1 mmHg, P = .04) and systemic vascular resistance (5800 +/- 2685-5144 +/- 2077 dyne x s/cm5, P = .03) were decreased by ACE inhibitors.
CONCLUSIONS AND CLINICAL IMPORTANCE: ACE inhibitors decrease LAP minimally, despite reductions in left ventricular afterload. ACE inhibitors should not be used to decrease LAP.
Authors:
T Ishikawa; R Tanaka; S Suzuki; Y Miyaishi; H Akagi; Y Iino; R Fukushima; Y Yamane
Related Documents :
12649357 - Beneficial effects of sampatrilat, a novel vasopeptidase inhibitor, on cardiac remodeli...
7898097 - Therapeutic experience with cilazapril.
21234767 - Adequacy of control of preoperative hypertension can affect landiolol-induced hemodynam...
23188217 - Length and pressure of the reconstructed lower esophageal sphincter is determined by bo...
8555527 - Dynamic biventricular response to alterations in preload in patients undergoing left ve...
7009427 - Renal artery stenosis with normal angiotensin ii values. relationship between angiotens...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of veterinary internal medicine / American College of Veterinary Internal Medicine     Volume:  24     ISSN:  0891-6640     ISO Abbreviation:  J. Vet. Intern. Med.     Publication Date:    2010 Mar-Apr
Date Detail:
Created Date:  2010-05-17     Completed Date:  2010-06-03     Revised Date:  2014-01-09    
Medline Journal Info:
Nlm Unique ID:  8708660     Medline TA:  J Vet Intern Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  342-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Animals
Atrial Function, Left / drug effects*
Blood Pressure / drug effects
Captopril / analogs & derivatives,  therapeutic use
Circadian Rhythm
Dog Diseases / drug therapy*
Dogs
Enalapril / therapeutic use
Female
Male
Mitral Valve Insufficiency / drug therapy,  veterinary*
Thiazepines / therapeutic use
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Thiazepines; 69PN84IO1A/Enalapril; 8G820I95VP/temocapril hydrochloride; 9G64RSX1XD/Captopril; X39TL7JDPF/alacepril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused ...
Next Document:  Modelling time to growth of Escherichia coli as a function of water activity and undissociated lacti...